Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
EPS for Prestige Consumer Healthcare (PBH)
EPS in 2023 (TTM): -$1.63
According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is -$1.63. In 2022 the company made an earnings per share (EPS) of $4.20 an increase over its 2021 EPS that were of $3.76.
EPS history for Prestige Consumer Healthcare from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.63 | -138.81% |
| 2022 | $4.20 | 11.7% |
| 2021 | $3.76 | 13.6% |
| 2020 | $3.31 | -651.67% |
| 2019 | -$0.60 | -148.78% |
| 2018 | $1.23 | -83.29% |
| 2017 | $7.36 | 437.23% |
| 2016 | $1.37 | -34.13% |
| 2015 | $2.08 | 52.94% |
| 2014 | $1.36 | -8.11% |
| 2013 | $1.48 | 62.64% |
| 2012 | $0.91 | 4.6% |
| 2011 | $0.87 | 70.59% |
| 2010 | $0.51 | -113.97% |
| 2009 | -$3.65 | -621.43% |
| 2008 | $0.70 | 7.69% |
| 2007 | $0.65 | 1.56% |
| 2006 | $0.64 | -681.82% |
| 2005 | -$0.11 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -964.13% | 🇺🇸 USA |
 Procter & Gamble PG | $6.33 | -488.34% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -329.45% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -214.11% | 🇺🇸 USA |
 Abbott Laboratories ABT | $2.97 | -282.34% | 🇺🇸 USA |
 Clorox CLX | $0.70 | -142.94% | 🇺🇸 USA |
 CVS Health CVS | $6.66 | -508.59% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -314.77% | 🇬🇧 UK |
 Rite Aid
RAD | -$29.62 | 1,717.18% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | $0.61 | -137.42% | 🇮🇱 Israel |